Impact of direct-acting antiviral therapy for hepatitis C–related hepatocellular carcinoma

With the introduction of direct-acting antiviral (DAA) agents, hepatitis C virus (HCV) treatment has dramatically improved. However, there are insufficient data on the benefits of DAA therapy in hepatocellular carcinoma (HCC). The purpose of this study was to investigate the outcome of patients who...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Wei-Chen, Lin, Yang-Sheng, Chang, Chen-Wang, Chang, Ching-Wei, Wang, Tsang-En, Wang, Horng-Yuan, Chen, Ming-Jen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7244104/
https://www.ncbi.nlm.nih.gov/pubmed/32442193
http://dx.doi.org/10.1371/journal.pone.0233212

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7244104/
https://www.ncbi.nlm.nih.gov/pubmed/32442193
http://dx.doi.org/10.1371/journal.pone.0233212

Ejemplares similares